Investment into UK artificial intelligence companies reached £4.56 billion in the second quarter of 2026, setting a new quarterly record for the sector. The total was 4.1% higher than in the previous quarter and nearly three times the £1.59 billion raised by AI companies in the same quarter a year earlier, representing a 186.8% year-on-year increase. The result also surpassed the previous high of £4.38 billion set in the first quarter of 2026, confirming that AI fundraising has continued to climb even after an already strong start to the year.
The figures cover equity investment into private UK companies and show that AI remains one of the most powerful forces in the country's private-company market. Across all sectors, 1,070 equity deals worth £8.01 billion were tracked for the second quarter so far. AI companies accounted for about one in four of those deals, with 269 rounds in total, and took 57% of all invested capital. Because some unannounced deals are still being identified in Companies House filings, the final totals may be higher.
Key facts at a glance
- UK AI investment in Q2 2026: £4.56 billion
- Quarter-on-quarter growth: 4.1%
- Year-on-year growth: 186.8%
- Q2 2025 AI total: £1.59 billion
- Previous record: £4.38 billion in Q1 2026
- AI equity deals: 269, about one in four UK equity deals
- Share of invested capital: 57%
- All-sector equity deals tracked: 1,070, worth £8.01 billion
- Share of AI total raised by eight deals: 80%
- Largest AI raise: Isomorphic Labs, £1.47 billion
A landmark quarter driven by large rounds
The quarter was described as a landmark for UK AI investment not only because of the scale of capital committed but also because of the breadth of companies involved. Investment flowed across life sciences, AI infrastructure, financial services, advanced engineering and enterprise software. That range matters because it shows AI is not confined to a single consumer app or software niche; it is becoming embedded in industries that require deep technical expertise, long development cycles and significant capital.
However, the headline total was heavily influenced by a small number of very large fundraisings. Eight AI equity raises accounted for 80% of the total invested into UK AI during the quarter. Life sciences and health attracted the most investment by value. The largest deal was a £1.47 billion fundraise by life sciences start-up Isomorphic Labs. Other significant deals came from Ineffable Intelligence, data centre firm NScale, PhysicsX and chip start-up Fractile. The presence of these companies among the quarter's largest deals illustrates how AI investment is spreading across health, infrastructure, engineering and semiconductors.
Life sciences and health lead by value
Life sciences and health emerged as the leading sector by value. That position reflects the growing convergence between AI and biology, where machine learning is being applied to drug discovery, clinical development, diagnostics and research workflows. These fields generate vast datasets and involve complex problems that can benefit from computational models. AI-enabled life sciences companies often require large amounts of capital because they face long development timelines, expensive trials and regulatory hurdles. The scale of the Isomorphic Labs raise indicates that investors are willing to commit substantial sums to companies that combine AI with scientific research.
The concentration of value in life sciences and health also shows that AI investment is not limited to software businesses with relatively light capital needs. It now extends to fields where compute, laboratory work, specialist talent and data infrastructure are essential. The UK has long-standing strengths in life sciences, including research institutions, hospitals and a growing base of specialist companies. When those strengths combine with AI expertise, they can create companies capable of attracting international capital. The largest deal of the quarter helped push life sciences and health to the top of the value table, and it also signalled that investors are prepared to back ambitious, science-heavy AI ventures.
Infrastructure, chips and advanced engineering
AI infrastructure was another important part of the quarter. Data centre firm NScale was among the companies raising significant capital. The growth of AI models has increased demand for compute, power, cooling, networking and land, making data centre capacity a critical part of the AI supply chain. Financing infrastructure is different from financing software: projects can be capital-intensive, long-term and sensitive to energy costs and planning constraints. The presence of a data centre company among the largest AI deals shows that investors are looking beyond models and applications to the physical systems that support them.
Chip start-up Fractile was also among the notable fundraisings. AI workloads require specialised hardware, and semiconductor innovation is central to improving performance and efficiency. The UK has a history of strength in chip design and advanced engineering, and AI is creating new opportunities for companies that can design hardware tailored to demanding computational tasks. PhysicsX was another large deal in the quarter, adding to the picture of AI investment moving into engineering and simulation-heavy fields. Financial services and enterprise software also attracted investment, reinforcing the impression of a broad-based but highly concentrated funding environment.
Deal count and capital share
The AI sector's 269 equity deals represented about one in four of the 1,070 tracked across all sectors in the second quarter. Yet those AI deals captured 57% of invested capital. That gap between deal count and capital share shows that AI companies are raising disproportionately large amounts. The average AI round was therefore larger than the average round in the broader market. The concentration among eight raises also means that many smaller AI companies are likely raising more modest amounts, even as a handful of large deals dominate the headline figures.
Deal count remains important because early-stage activity builds the pipeline for future growth. A market that depends only on a few mega-rounds can be volatile, since quarterly totals may swing sharply if a single large deal is delayed or brought forward. A healthy ecosystem needs a broad base of start-ups raising seed and early-stage capital, alongside later-stage companies capable of absorbing large sums. The second-quarter data show both features: a small number of very large raises and a wider set of 269 AI deals across the market.
The all-sector total of £8.01 billion means AI accounted for more than half of tracked invested capital. The remaining capital was spread across other sectors, including life sciences, financial services, advanced engineering and enterprise software outside AI. The expected upward revision from unannounced deals is another reason to treat the figures as provisional. Companies House filings often appear with a lag, and some completed deals may not yet be reflected in the tracked totals. As more filings are processed, the second-quarter total could rise further.
Investor appetite in a selective market
The year-on-year increase was substantial. AI companies raised £1.59 billion in the same quarter a year earlier, so the £4.56 billion total represents a 186.8% increase. That is close to a tripling of investment in 12 months. The quarter-on-quarter rise was smaller at 4.1%, but it came on top of an already record-breaking first quarter. Two consecutive quarters above £4 billion suggest that AI fundraising has entered a new phase in the UK, with larger rounds becoming more common and investors willing to commit capital at scale.
The breadth of sectors cited in the analysis is a sign that AI is becoming a general-purpose technology. Life sciences, financial services, advanced engineering and enterprise software all have clear use cases for machine learning, from drug discovery and risk modelling to design optimisation and workflow automation. AI infrastructure supports those applications by providing the compute and data capacity they need. The UK's ability to attract investment across these areas reflects its existing strengths in research, financial services and engineering, as well as a growing cluster of AI-native companies.
There are limits to what one quarter can show. Equity investment figures do not capture debt, grants, strategic partnerships or revenue-based financing. Large rounds can reflect the capital intensity of a particular business model rather than a broad increase in the number of companies being funded. Valuation changes and investor sentiment can also move quarterly totals. Even so, the combination of a record total, a steep year-on-year rise and a wide spread of sectors provides a strong signal of investor interest.
The concentration of 80% of capital in eight deals remains the defining feature of the quarter. It means the record was not driven by an even uplift across hundreds of companies. Instead, a handful of ambitious companies attracted the lion's share of capital. Isomorphic Labs alone raised £1.47 billion, a sum large enough to shape the quarterly total. The other large deals, including Ineffable Intelligence, NScale, PhysicsX and Fractile, added to the concentration and showed that investors are backing companies in life sciences, infrastructure, engineering and chips.
For the UK ecosystem, the challenge is to convert these large raises into lasting growth. Big funding rounds can support hiring, research and infrastructure, but they also create expectations for commercial progress. A broad base of smaller AI companies will need access to capital if the sector is to produce a steady pipeline of future scale-ups. The second-quarter figures show that the UK can attract very large AI cheques. The next set of filings will be watched for whether the eight-deal concentration persists or gives way to a broader base of AI fundraising.
Source: Silicon UK News